Xencor Inc . (NASDAQ:XNCR), a biopharmaceutical company specializing in innovative therapies for immunology and oncology, ...

The Protein Sequencing Companytm, announces the formation of its Scientific Advisory Board. Comprised of distinguished experts in proteomics, genomics, bioinformatics, chemistry, ...

COUR Pharmaceuticals, a clinical-stage biotechnology company developing first-in-class, disease-modifying therapies designed ...

Financing led by CARMA FUND and RV Invest with participation of High-Tech Gründerfonds and othersAkribion is pioneering a unique, RNA-guided, nuclease-based technology for programmable cell ...

As the CBSE Class 10 Science Board exam approaches on February 20, 2025, students are refining their preparation strategies.

Eligible candidates can apply for the Graduate Aptitude Test- Biotechnology (GAT-B) 2025 at exams.nta.ac.in up to March 3.

Subin Baral, EY global life sciences deals leader, told GEN M&A deals are expected to increase in 2025, driven by biopharmas that are eager to recoup revenues they expect to lose as their aging ...

Adding US stocks to your investment portfolio can offer growth potential, stability, and diversification. Indian investors ...

Fresh from its landmark US regulatory approval for its stem-cell product for paediatric graft-versus-host disease (GvHD), ...

Finerenone is the first drug targeting the mineralocorticoid receptor (MR) pathway to demonstrate cardiovascular benefits in a Phase III study in patients ...

The candidates who wish to apply for JEE Main 2025 session two can do so on the official website- jeemain.nta.nic.in. The ...